Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
- PMID: 26104564
- PMCID: PMC8162739
- DOI: 10.1128/microbiolspec.AID-0027-2014
Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
Abstract
The human hybridoma technique offers an important approach for isolation of human monoclonal antibodies. A diversity of approaches can be used with varying success. Recent technical advances in expanding the starting number of human antigen-specific B cells, improving fusion efficiency, and isolating new myeloma partners and new cell cloning methods have enabled the development of protocols that make the isolation of human monoclonal antibodies from blood samples feasible. Undoubtedly, additional innovations that could improve efficiency are possible.
Conflict of interest statement
Conflicts of interest: We disclose no conflicts.
Figures
References
-
- Kohler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497. - PubMed
-
- Schwaber J, Cohen EP. 1973. Human × mouse somatic cell hybrid clone secreting immunoglobulins of both parental types. Nature 244:444–447. - PubMed
-
- Stevens RH, Macy E, Morrow C, Saxon A. 1979. Characterization of a circulating subpopulation of spontaneous anti-tetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 122:2498–2504. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
